Request for Covid-19 Impact Assessment of this Report
The United States Anti-Malarial Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Anti-Malarial Drug market, reaching US$ million by the year 2028. As for the Europe Anti-Malarial Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Anti-Malarial Drug players cover GlaxoSmithKline, Ranbaxy, Zydus Cadila, and Alvizia, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Malarial Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Plasmodium Falciparum
Plasmodium Vivax
Plasmodium Malariae
Plasmodium Ovale
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital Pharmacy
Retail Pharmacy
E-Commerce
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GlaxoSmithKline
Ranbaxy
Zydus Cadila
Alvizia
Bayer
Ipca
Merck
F. Hoffmann-La Roche
Novartis
Pfizer
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-Malarial Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Anti-Malarial Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Anti-Malarial Drug by Country/Region, 2017, 2022 & 2028
2.2 Anti-Malarial Drug Segment by Type
2.2.1 Plasmodium Falciparum
2.2.2 Plasmodium Vivax
2.2.3 Plasmodium Malariae
2.2.4 Plasmodium Ovale
2.3 Anti-Malarial Drug Sales by Type
2.3.1 Global Anti-Malarial Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Anti-Malarial Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Anti-Malarial Drug Sale Price by Type (2017-2022)
2.4 Anti-Malarial Drug Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 E-Commerce
2.4.4 Others
2.5 Anti-Malarial Drug Sales by Application
2.5.1 Global Anti-Malarial Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Anti-Malarial Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Anti-Malarial Drug Sale Price by Application (2017-2022)
3 Global Anti-Malarial Drug by Company
3.1 Global Anti-Malarial Drug Breakdown Data by Company
3.1.1 Global Anti-Malarial Drug Annual Sales by Company (2020-2022)
3.1.2 Global Anti-Malarial Drug Sales Market Share by Company (2020-2022)
3.2 Global Anti-Malarial Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Anti-Malarial Drug Revenue by Company (2020-2022)
3.2.2 Global Anti-Malarial Drug Revenue Market Share by Company (2020-2022)
3.3 Global Anti-Malarial Drug Sale Price by Company
3.4 Key Manufacturers Anti-Malarial Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Malarial Drug Product Location Distribution
3.4.2 Players Anti-Malarial Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Anti-Malarial Drug by Geographic Region
4.1 World Historic Anti-Malarial Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Anti-Malarial Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Anti-Malarial Drug Annual Revenue by Geographic Region
4.2 World Historic Anti-Malarial Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Anti-Malarial Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Anti-Malarial Drug Annual Revenue by Country/Region
4.3 Americas Anti-Malarial Drug Sales Growth
4.4 APAC Anti-Malarial Drug Sales Growth
4.5 Europe Anti-Malarial Drug Sales Growth
4.6 Middle East & Africa Anti-Malarial Drug Sales Growth
5 Americas
5.1 Americas Anti-Malarial Drug Sales by Country
5.1.1 Americas Anti-Malarial Drug Sales by Country (2017-2022)
5.1.2 Americas Anti-Malarial Drug Revenue by Country (2017-2022)
5.2 Americas Anti-Malarial Drug Sales by Type
5.3 Americas Anti-Malarial Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Malarial Drug Sales by Region
6.1.1 APAC Anti-Malarial Drug Sales by Region (2017-2022)
6.1.2 APAC Anti-Malarial Drug Revenue by Region (2017-2022)
6.2 APAC Anti-Malarial Drug Sales by Type
6.3 APAC Anti-Malarial Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Anti-Malarial Drug by Country
7.1.1 Europe Anti-Malarial Drug Sales by Country (2017-2022)
7.1.2 Europe Anti-Malarial Drug Revenue by Country (2017-2022)
7.2 Europe Anti-Malarial Drug Sales by Type
7.3 Europe Anti-Malarial Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anti-Malarial Drug by Country
8.1.1 Middle East & Africa Anti-Malarial Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Anti-Malarial Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Anti-Malarial Drug Sales by Type
8.3 Middle East & Africa Anti-Malarial Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-Malarial Drug
10.3 Manufacturing Process Analysis of Anti-Malarial Drug
10.4 Industry Chain Structure of Anti-Malarial Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-Malarial Drug Distributors
11.3 Anti-Malarial Drug Customer
12 World Forecast Review for Anti-Malarial Drug by Geographic Region
12.1 Global Anti-Malarial Drug Market Size Forecast by Region
12.1.1 Global Anti-Malarial Drug Forecast by Region (2023-2028)
12.1.2 Global Anti-Malarial Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti-Malarial Drug Forecast by Type
12.7 Global Anti-Malarial Drug Forecast by Application
13 Key Players Analysis
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Anti-Malarial Drug Product Offered
13.1.3 GlaxoSmithKline Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Ranbaxy
13.2.1 Ranbaxy Company Information
13.2.2 Ranbaxy Anti-Malarial Drug Product Offered
13.2.3 Ranbaxy Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Ranbaxy Main Business Overview
13.2.5 Ranbaxy Latest Developments
13.3 Zydus Cadila
13.3.1 Zydus Cadila Company Information
13.3.2 Zydus Cadila Anti-Malarial Drug Product Offered
13.3.3 Zydus Cadila Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Zydus Cadila Main Business Overview
13.3.5 Zydus Cadila Latest Developments
13.4 Alvizia
13.4.1 Alvizia Company Information
13.4.2 Alvizia Anti-Malarial Drug Product Offered
13.4.3 Alvizia Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Alvizia Main Business Overview
13.4.5 Alvizia Latest Developments
13.5 Bayer
13.5.1 Bayer Company Information
13.5.2 Bayer Anti-Malarial Drug Product Offered
13.5.3 Bayer Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Bayer Main Business Overview
13.5.5 Bayer Latest Developments
13.6 Ipca
13.6.1 Ipca Company Information
13.6.2 Ipca Anti-Malarial Drug Product Offered
13.6.3 Ipca Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Ipca Main Business Overview
13.6.5 Ipca Latest Developments
13.7 Merck
13.7.1 Merck Company Information
13.7.2 Merck Anti-Malarial Drug Product Offered
13.7.3 Merck Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Merck Main Business Overview
13.7.5 Merck Latest Developments
13.8 F. Hoffmann-La Roche
13.8.1 F. Hoffmann-La Roche Company Information
13.8.2 F. Hoffmann-La Roche Anti-Malarial Drug Product Offered
13.8.3 F. Hoffmann-La Roche Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 F. Hoffmann-La Roche Main Business Overview
13.8.5 F. Hoffmann-La Roche Latest Developments
13.9 Novartis
13.9.1 Novartis Company Information
13.9.2 Novartis Anti-Malarial Drug Product Offered
13.9.3 Novartis Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Novartis Main Business Overview
13.9.5 Novartis Latest Developments
13.10 Pfizer
13.10.1 Pfizer Company Information
13.10.2 Pfizer Anti-Malarial Drug Product Offered
13.10.3 Pfizer Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Pfizer Main Business Overview
13.10.5 Pfizer Latest Developments
14 Research Findings and Conclusion
Table 1. Anti-Malarial Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Anti-Malarial Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Plasmodium Falciparum
Table 4. Major Players of Plasmodium Vivax
Table 5. Major Players of Plasmodium Malariae
Table 6. Major Players of Plasmodium Ovale
Table 7. Global Anti-Malarial Drug Sales by Type (2017-2022) & (MT)
Table 8. Global Anti-Malarial Drug Sales Market Share by Type (2017-2022)
Table 9. Global Anti-Malarial Drug Revenue by Type (2017-2022) & ($ million)
Table 10. Global Anti-Malarial Drug Revenue Market Share by Type (2017-2022)
Table 11. Global Anti-Malarial Drug Sale Price by Type (2017-2022) & (USD/Kg)
Table 12. Global Anti-Malarial Drug Sales by Application (2017-2022) & (MT)
Table 13. Global Anti-Malarial Drug Sales Market Share by Application (2017-2022)
Table 14. Global Anti-Malarial Drug Revenue by Application (2017-2022)
Table 15. Global Anti-Malarial Drug Revenue Market Share by Application (2017-2022)
Table 16. Global Anti-Malarial Drug Sale Price by Application (2017-2022) & (USD/Kg)
Table 17. Global Anti-Malarial Drug Sales by Company (2020-2022) & (MT)
Table 18. Global Anti-Malarial Drug Sales Market Share by Company (2020-2022)
Table 19. Global Anti-Malarial Drug Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Anti-Malarial Drug Revenue Market Share by Company (2020-2022)
Table 21. Global Anti-Malarial Drug Sale Price by Company (2020-2022) & (USD/Kg)
Table 22. Key Manufacturers Anti-Malarial Drug Producing Area Distribution and Sales Area
Table 23. Players Anti-Malarial Drug Products Offered
Table 24. Anti-Malarial Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Anti-Malarial Drug Sales by Geographic Region (2017-2022) & (MT)
Table 28. Global Anti-Malarial Drug Sales Market Share Geographic Region (2017-2022)
Table 29. Global Anti-Malarial Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Anti-Malarial Drug Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Anti-Malarial Drug Sales by Country/Region (2017-2022) & (MT)
Table 32. Global Anti-Malarial Drug Sales Market Share by Country/Region (2017-2022)
Table 33. Global Anti-Malarial Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Anti-Malarial Drug Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Anti-Malarial Drug Sales by Country (2017-2022) & (MT)
Table 36. Americas Anti-Malarial Drug Sales Market Share by Country (2017-2022)
Table 37. Americas Anti-Malarial Drug Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Anti-Malarial Drug Revenue Market Share by Country (2017-2022)
Table 39. Americas Anti-Malarial Drug Sales by Type (2017-2022) & (MT)
Table 40. Americas Anti-Malarial Drug Sales Market Share by Type (2017-2022)
Table 41. Americas Anti-Malarial Drug Sales by Application (2017-2022) & (MT)
Table 42. Americas Anti-Malarial Drug Sales Market Share by Application (2017-2022)
Table 43. APAC Anti-Malarial Drug Sales by Region (2017-2022) & (MT)
Table 44. APAC Anti-Malarial Drug Sales Market Share by Region (2017-2022)
Table 45. APAC Anti-Malarial Drug Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Anti-Malarial Drug Revenue Market Share by Region (2017-2022)
Table 47. APAC Anti-Malarial Drug Sales by Type (2017-2022) & (MT)
Table 48. APAC Anti-Malarial Drug Sales Market Share by Type (2017-2022)
Table 49. APAC Anti-Malarial Drug Sales by Application (2017-2022) & (MT)
Table 50. APAC Anti-Malarial Drug Sales Market Share by Application (2017-2022)
Table 51. Europe Anti-Malarial Drug Sales by Country (2017-2022) & (MT)
Table 52. Europe Anti-Malarial Drug Sales Market Share by Country (2017-2022)
Table 53. Europe Anti-Malarial Drug Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Anti-Malarial Drug Revenue Market Share by Country (2017-2022)
Table 55. Europe Anti-Malarial Drug Sales by Type (2017-2022) & (MT)
Table 56. Europe Anti-Malarial Drug Sales Market Share by Type (2017-2022)
Table 57. Europe Anti-Malarial Drug Sales by Application (2017-2022) & (MT)
Table 58. Europe Anti-Malarial Drug Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Anti-Malarial Drug Sales by Country (2017-2022) & (MT)
Table 60. Middle East & Africa Anti-Malarial Drug Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Anti-Malarial Drug Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Anti-Malarial Drug Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Anti-Malarial Drug Sales by Type (2017-2022) & (MT)
Table 64. Middle East & Africa Anti-Malarial Drug Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Anti-Malarial Drug Sales by Application (2017-2022) & (MT)
Table 66. Middle East & Africa Anti-Malarial Drug Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Anti-Malarial Drug
Table 68. Key Market Challenges & Risks of Anti-Malarial Drug
Table 69. Key Industry Trends of Anti-Malarial Drug
Table 70. Anti-Malarial Drug Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Anti-Malarial Drug Distributors List
Table 73. Anti-Malarial Drug Customer List
Table 74. Global Anti-Malarial Drug Sales Forecast by Region (2023-2028) & (MT)
Table 75. Global Anti-Malarial Drug Sales Market Forecast by Region
Table 76. Global Anti-Malarial Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Anti-Malarial Drug Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Anti-Malarial Drug Sales Forecast by Country (2023-2028) & (MT)
Table 79. Americas Anti-Malarial Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Anti-Malarial Drug Sales Forecast by Region (2023-2028) & (MT)
Table 81. APAC Anti-Malarial Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Anti-Malarial Drug Sales Forecast by Country (2023-2028) & (MT)
Table 83. Europe Anti-Malarial Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Anti-Malarial Drug Sales Forecast by Country (2023-2028) & (MT)
Table 85. Middle East & Africa Anti-Malarial Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Anti-Malarial Drug Sales Forecast by Type (2023-2028) & (MT)
Table 87. Global Anti-Malarial Drug Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Anti-Malarial Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Anti-Malarial Drug Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Anti-Malarial Drug Sales Forecast by Application (2023-2028) & (MT)
Table 91. Global Anti-Malarial Drug Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Anti-Malarial Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Anti-Malarial Drug Revenue Market Share Forecast by Application (2023-2028)
Table 94. GlaxoSmithKline Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. GlaxoSmithKline Anti-Malarial Drug Product Offered
Table 96. GlaxoSmithKline Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 97. GlaxoSmithKline Main Business
Table 98. GlaxoSmithKline Latest Developments
Table 99. Ranbaxy Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Ranbaxy Anti-Malarial Drug Product Offered
Table 101. Ranbaxy Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 102. Ranbaxy Main Business
Table 103. Ranbaxy Latest Developments
Table 104. Zydus Cadila Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Zydus Cadila Anti-Malarial Drug Product Offered
Table 106. Zydus Cadila Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 107. Zydus Cadila Main Business
Table 108. Zydus Cadila Latest Developments
Table 109. Alvizia Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. Alvizia Anti-Malarial Drug Product Offered
Table 111. Alvizia Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 112. Alvizia Main Business
Table 113. Alvizia Latest Developments
Table 114. Bayer Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. Bayer Anti-Malarial Drug Product Offered
Table 116. Bayer Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 117. Bayer Main Business
Table 118. Bayer Latest Developments
Table 119. Ipca Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Ipca Anti-Malarial Drug Product Offered
Table 121. Ipca Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 122. Ipca Main Business
Table 123. Ipca Latest Developments
Table 124. Merck Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 125. Merck Anti-Malarial Drug Product Offered
Table 126. Merck Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 127. Merck Main Business
Table 128. Merck Latest Developments
Table 129. F. Hoffmann-La Roche Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 130. F. Hoffmann-La Roche Anti-Malarial Drug Product Offered
Table 131. F. Hoffmann-La Roche Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 132. F. Hoffmann-La Roche Main Business
Table 133. F. Hoffmann-La Roche Latest Developments
Table 134. Novartis Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 135. Novartis Anti-Malarial Drug Product Offered
Table 136. Novartis Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 137. Novartis Main Business
Table 138. Novartis Latest Developments
Table 139. Pfizer Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 140. Pfizer Anti-Malarial Drug Product Offered
Table 141. Pfizer Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 142. Pfizer Main Business
Table 143. Pfizer Latest Developments
List of Figures
Figure 1. Picture of Anti-Malarial Drug
Figure 2. Anti-Malarial Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Malarial Drug Sales Growth Rate 2017-2028 (MT)
Figure 7. Global Anti-Malarial Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Anti-Malarial Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Plasmodium Falciparum
Figure 10. Product Picture of Plasmodium Vivax
Figure 11. Product Picture of Plasmodium Malariae
Figure 12. Product Picture of Plasmodium Ovale
Figure 13. Global Anti-Malarial Drug Sales Market Share by Type in 2021
Figure 14. Global Anti-Malarial Drug Revenue Market Share by Type (2017-2022)
Figure 15. Anti-Malarial Drug Consumed in Hospital Pharmacy
Figure 16. Global Anti-Malarial Drug Market: Hospital Pharmacy (2017-2022) & (MT)
Figure 17. Anti-Malarial Drug Consumed in Retail Pharmacy
Figure 18. Global Anti-Malarial Drug Market: Retail Pharmacy (2017-2022) & (MT)
Figure 19. Anti-Malarial Drug Consumed in E-Commerce
Figure 20. Global Anti-Malarial Drug Market: E-Commerce (2017-2022) & (MT)
Figure 21. Anti-Malarial Drug Consumed in Others
Figure 22. Global Anti-Malarial Drug Market: Others (2017-2022) & (MT)
Figure 23. Global Anti-Malarial Drug Sales Market Share by Application (2017-2022)
Figure 24. Global Anti-Malarial Drug Revenue Market Share by Application in 2021
Figure 25. Anti-Malarial Drug Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Anti-Malarial Drug Revenue Market Share by Company in 2021
Figure 27. Global Anti-Malarial Drug Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Anti-Malarial Drug Revenue Market Share by Geographic Region in 2021
Figure 29. Global Anti-Malarial Drug Sales Market Share by Region (2017-2022)
Figure 30. Global Anti-Malarial Drug Revenue Market Share by Country/Region in 2021
Figure 31. Americas Anti-Malarial Drug Sales 2017-2022 (MT)
Figure 32. Americas Anti-Malarial Drug Revenue 2017-2022 ($ Millions)
Figure 33. APAC Anti-Malarial Drug Sales 2017-2022 (MT)
Figure 34. APAC Anti-Malarial Drug Revenue 2017-2022 ($ Millions)
Figure 35. Europe Anti-Malarial Drug Sales 2017-2022 (MT)
Figure 36. Europe Anti-Malarial Drug Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Anti-Malarial Drug Sales 2017-2022 (MT)
Figure 38. Middle East & Africa Anti-Malarial Drug Revenue 2017-2022 ($ Millions)
Figure 39. Americas Anti-Malarial Drug Sales Market Share by Country in 2021
Figure 40. Americas Anti-Malarial Drug Revenue Market Share by Country in 2021
Figure 41. United States Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Anti-Malarial Drug Sales Market Share by Region in 2021
Figure 46. APAC Anti-Malarial Drug Revenue Market Share by Regions in 2021
Figure 47. China Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Anti-Malarial Drug Sales Market Share by Country in 2021
Figure 54. Europe Anti-Malarial Drug Revenue Market Share by Country in 2021
Figure 55. Germany Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Anti-Malarial Drug Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Anti-Malarial Drug Revenue Market Share by Country in 2021
Figure 62. Egypt Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Anti-Malarial Drug in 2021
Figure 68. Manufacturing Process Analysis of Anti-Malarial Drug
Figure 69. Industry Chain Structure of Anti-Malarial Drug
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...